These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 16613337)

  • 1. The quality of laboratory testing today: an assessment of sigma metrics for analytic quality using performance data from proficiency testing surveys and the CLIA criteria for acceptable performance.
    Westgard JO; Westgard SA
    Am J Clin Pathol; 2006 Mar; 125(3):343-54. PubMed ID: 16613337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory precision performance: state of the art versus operating specifications that assure the analytical quality required by clinical laboratory improvement amendments proficiency testing.
    Westgard JO; Bawa N; Ross JW; Lawson NS
    Arch Pathol Lab Med; 1996 Jul; 120(7):621-5. PubMed ID: 8757464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical laboratory performance on proficiency testing samples--United States, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Mar; 45(9):193-6. PubMed ID: 8604217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Has compliance with CLIA requirements really improved quality in US clinical laboratories?
    Ehrmeyer SS; Laessig RH
    Clin Chim Acta; 2004 Aug; 346(1):37-43. PubMed ID: 15234634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final CLIA regulations. Clinical Laboratory Improvement Amendments.
    Health Devices; 1992 Nov; 21(11):420-5. PubMed ID: 1428896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)--HCFA. Final rule with comment period.
    Fed Regist; 1992 Feb; 57(40):7002-186. PubMed ID: 10170937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Common diagnostic tests under the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) in the United States].
    Takemura Y
    Rinsho Byori; 2002 Jan; 50(1):61-7. PubMed ID: 11871138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with the Clinical Laboratory Improvement Amendments of 1988 for hemoglobin screening--California, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 May; 45(20):419-22. PubMed ID: 8614398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal quality control, proficiency testing, and the clinical relevance of laboratory testing.
    Kafka MT
    Arch Pathol Lab Med; 1988 Apr; 112(4):449-53. PubMed ID: 3355347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLIA program; simplifying CLIA regulations relating to accreditation, exemption of laboratories under a state licensure program, proficiency testing, and inspection--HCFA. Final rule.
    Fed Regist; 1998 May; 63(93):26722-38. PubMed ID: 10179342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality improvement of diagnostic microbiology through a peer-group proficiency assessment program. A 20-year experience in Ontario. The Microbiology Committee.
    Richardson H; Wood D; Whitby J; Lannigan R; Fleming C
    Arch Pathol Lab Med; 1996 May; 120(5):445-55. PubMed ID: 8639047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Kodak DT-60 physician's office analyzer as measured by CLIA-88 proposed evaluation criteria. Assessment of demographic and quality assurance factors influencing performance.
    Meier S; Ehrmeyer S; Laessig R; Woodlief G; Lanphear B; Hassemer D
    Arch Pathol Lab Med; 1992 May; 116(5):524-30. PubMed ID: 1580758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the impact of a CD4+ T-cell testing laboratory improvement program.
    Rosner E; Siragusa M; Schalla W; Cross D; Cohn R; Hearn T
    Arch Pathol Lab Med; 1998 Jun; 122(6):512-9. PubMed ID: 9625418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of implementation of the Clinical Laboratory Improvement Amendments of 1988--the example of pediatric office-based cholesterol screening.
    Tershakovec AM; Brannon SD; Bennett MJ; Shannon BM
    Pediatrics; 1995 Aug; 96(2 Pt 1):230-4. PubMed ID: 7630675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix effects and the accuracy of cholesterol analysis.
    Ross JW; Myers GL; Gilmore BF; Cooper GR; Naito HR; Eckfeldt J
    Arch Pathol Lab Med; 1993 Apr; 117(4):393-400. PubMed ID: 8466403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix effects on proficiency testing materials. Impact on accuracy of cholesterol measurement in laboratories in the nation's largest hospital system.
    Naito HK; Kwak YS; Hartfiel JL; Park JK; Travers EM; Myers GL; Ross JW; Eckfeldt JH; Hartmann AE
    Arch Pathol Lab Med; 1993 Apr; 117(4):345-51. PubMed ID: 8466396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The external quality assessment schemes in Thailand.
    Opartkiattikul N; Bejrachandra S
    Rinsho Byori; 2002 Feb; 50(2):121-5. PubMed ID: 11925846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical immunohistochemistry laboratory: regulations and troubleshooting guidelines.
    Fetsch PA; Abati A
    Methods Mol Biol; 2010; 588():399-412. PubMed ID: 20012854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving successful proficiency testing.
    Clin Leadersh Manag Rev; 2002; 16(5):328-30. PubMed ID: 12298443
    [No Abstract]   [Full Text] [Related]  

  • 20. Proficiency testing in laboratory medicine: uses and limitations.
    Shahangian S
    Arch Pathol Lab Med; 1998 Jan; 122(1):15-30. PubMed ID: 9448012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.